Ketosis Medicine Subject to Urgent Recall Warning

All current quantities of Kexxtone 32.4g continuous release intraruminal devices for cattle are subject to an urgent recall warning.

A quality flaw has led the UK regulator, the Veterinary Medicines Directorate (VMD), to declare a recall for the treatment, which is intended to lower the incidence of ketosis.

Cattle were reported to have regurgitated the device while the monensin pills were still within. This led to a possible lack of effectiveness in cattle as well as a greater likelihood of unintentional exposure in other species such as dogs.

VMD stated: “Due to a change in manufacturing process, a quality defect arose that led to an increase in regurgitation of boluses by cattle that still contained monensin tablets.

“This led to concerns over lack of efficacy in cattle and increased risk of accidental exposure to regurgitated Kexxtone devices by non-target species, with a corresponding link to death in dogs.”